In this insightful interview, Michèle Stokes, Ph.D., VP of the Asia Pacific Region at PCI Pharma Services, offered the crew a tour of their Melbourne facility. Michèle discusses the exciting direction of the industry, focusing on the rapid growth of mRNA technologies and the emergence of personalized, precision medicines driven by cell and gene therapies. She also offers a glimpse into PCI’s advanced temperature-controlled warehousing and explains how the company is supporting innovators in Australia's booming biopharma clinical trials landscape and the APAC region.
